Tsukuba, Japan

Naoaki Watanabe

This inventor holds 8 USPTO granted patents and 2 published patent applications. Top assignees: Eisai R&d Management Co., Ltd., Eisai Company, Limited. Active years: 2008-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoaki Watanabe. Retrieved from https://idiyas.com/inventor/naoaki-watanabe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 12.5

Average Co-Inventor Count = 8.2

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2008-2013

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Naoaki Watanabe: Innovator in Anti-Fungal Agents

Introduction

Naoaki Watanabe is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-fungal agents. With a total of eight patents to his name, Watanabe's work has had a considerable impact on medical science.

Latest Patents

Watanabe's latest patents include innovative compounds such as pyridine derivatives substituted by heterocyclic rings and phosphonoamino groups. These compounds are designed to serve as effective anti-fungal agents, showcasing excellent physicochemical properties, including safety and water solubility. One of his notable inventions involves a compound represented by a specific formula, which includes various substituents that enhance its efficacy against fungal infections. Additionally, he has developed isolated DNA encoding a GWT1 protein, which plays a crucial role in conferring resistance to fungi against specific compounds.

Career Highlights

Throughout his career, Watanabe has worked with notable companies, including Eisai R&D Management Co., Ltd. and Eisai Company, Limited. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects in the pharmaceutical industry.

Collaborations

Watanabe has collaborated with esteemed colleagues such as Keigo Tanaka and Kazutaka Nakamoto. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.

Conclusion

Naoaki Watanabe's contributions to the development of anti-fungal agents and his innovative approach to pharmaceutical research have established him as a key figure in the industry. His work continues to influence the field and offers promising solutions for combating fungal infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…